1. Turkey Stocks

  2. •

    Finance

  3. •

    Investment managers
Guler Yatirim Holding A.S.

Guler Yatirim Holding A.S.

BBIST:GLRYH
1.40
TRY
-0.11
(-7.28%)
2.29EPS
5.21P/E
1.94BMarket Cap
Guler Yatirim Holding A.S.
BIST:GLRYH
(Istanbul Exchange)

Recent

price

1.40

P/E

ratio

5.21

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
TRY
4.94
7.77
- -
0.04
0.18
0.15
0.2
1.74
1.62
0.84
4.8
7.51
32.93
31.18
60.16
56.75
60.49
Revenue per Share
- -
- -
-0.01
- -
0.02
0.02
0.01
- -
0.01
0.01
0.08
0.15
0.43
0.21
0.33
1.99
0.62
Basic EPS, GAAP
- -
-0.01
-0.01
-0.01
0.03
0.04
-0.03
-0.03
0.02
-0.07
-0.09
-0.06
0.26
0.89
-0.6
4.7
9.71
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.06
0.04
0.05
0.05
0.07
0.08
0.06
0.1
0.07
0.07
0.16
0.41
0.89
1.73
2.79
8.78
9.46
Book Value per Share
0.06
0.04
0.04
0.05
0.06
0.08
0.06
0.1
0.06
0.07
0.15
0.41
0.87
1.7
2.76
8.71
9.39
Tangible Book Value per Share
206
220
220
697
220
220
391
388
727
727
727
926
926
926
926
600
600
Basic Weighted Avg Shares
1,016
1,707
- -
28
39
33
77
676
1,179
613
3,489
6,955
30,487
28,865
55,698
34,047
36,295
Sales/Revenue/Turnover
0.01
-0.13
- -
-1.75
13.45
2.75
5.36
0.03
1.18
1.74
5
7.28
6.34
9.65
8.76
26.25
16.95
Operating Margin (%)
- -
- -
- -
- -
- -
1
- -
1
1
3
3
8
59
148
751
370
346
Depreciation Expense
- -
- -
-1
2
4
4
3
- -
11
4
57
142
398
198
302
1,195
373
Net Income, GAAP
- -
- -
- -
20
0.92
- -
16.06
118.96
- -
24.01
21.18
11.55
60.94
58.48
50.26
37.86
50.28
Effective Tax Rate (%)
0.01
-0.03
- -
5.39
11.33
11.92
4.3
-0.01
0.92
0.64
1.63
2.04
1.3
0.69
0.54
3.51
1.03
Profit Margin (%)
12
9
12
12
17
15
23
38
52
81
184
405
1,676
4,031
4,461
10,040
9,743
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
6
3
3
390
469
739
553
402
LT Debt
12
10
15
18
14
20
27
42
101
128
254
876
3,593
7,764
12,647
17,138
18,092
Total Equity
0.7
- -
- -
-2.41
26.7
- -
9.93
-0.27
- -
5.41
37.99
52.06
25.45
16.65
19.27
30.28
15.66
Return on Invested Capital (%)
0.7
- -
- -
9.93
27.19
- -
9.75
-0.81
- -
0.6
-0.71
-7.55
22.5
7.5
8.54
-1.02
1.34
Return on Capital (%)
0.77
-4.05
-11.9
13.84
34.49
23.69
14.98
-0.12
23.12
7.44
68.06
57.16
46.03
10.01
8.84
25.2
7.87
Return on Common Equity (%)

Capital Structure

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2,410
1,838
3,630
LT Borrowings
396
360
305
LT Finance Leases
157
131
97
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
600
600
600
Market Capitalization
2,244
2,376
1,944

Working Capital

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
17,801
15,753
18,398
Cash, Cash Equivalents & STI
8,248
7,186
7,269
Accounts Receivable, Net
7,889
8,171
10,510
Inventories
48
48
45
Total Current Liabilities
7,761
6,164
8,655
Payables & Accruals
- -
- -
- -
ST Debt
2,410
1,838
3,630
Deferred Revenue
- -
- -
- -

Growth Rates

TRY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
112.41%
153.82%
35.51%
Free Cash Flow
-195.45%
-208.29%
-611.03%
Net Income, GAAP
-2,571.96%
125.63%
295.83%
Sales/Revenue/Turnover
189.59%
97.3%
-38.87%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
17,425
21,079
4,926
6,958
55,698
2025
6,507
7,640
11,754
10,410
34,047
2026
6,961
7,170
- -
- -
- -

Quarterly Earnings Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.31
0.05
-0.08
0.02
0.33
2025
0.38
0.4
0.2
1.14
1.99
2026
-0.58
-0.13
- -
- -
- -

Quarterly Dividends Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Morgan Stanley (NYSE:MS)
BlackRock, Inc. (NYSE:BLK)
Motilal Oswal Financial Services Limited (NSE:MOTILALOFS)
HDFC Asset Management Co. Ltd. (NSE:HDFCAMC)
Blackstone Inc. (NYSE:BX)
360 One Wam Limited (NSE:360ONE)
Business
Guler Yatirim Holding A.S. is a Turkey-based investment holding company primarily engaged in financial services, capital markets brokerage, venture capital, healthcare diagnostics, and renewable energy. Founded in 2006 and headquartered in Istanbul, Turkey, the company operates as the parent entity for a diversified group of operating subsidiaries and equity participations. Through its specialized business divisions, Guler Yatirim Holding provides a broad spectrum of products and services, including: equity and fixed-income brokerage; margin lending; derivatives and futures trading; repo and reverse repo transactions; corporate finance advisory, mergers and acquisitions consulting, and initial public offering underwriting; asset management, discretionary portfolio management, and investment fund administration via A1 Capital Yatirim Menkul Degerler A.S. and A1 Portfoy Yonetimi A.S.; venture capital financing, growth-stage private equity investments, and strategic startup incubation via Pardus Girisim Sermayesi Yatirim Ortakligi A.S. and Guler Girisim Sermayesi Yatirim Ortakligi A.S.; in vitro diagnostic test kits, real-time polymerase chain reaction testing solutions, clinical microbiology culture media, and laboratory diagnostic equipment via RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S.; and solar photovoltaic power generation and clean energy asset management through its energy subsidiaries. The company caters to retail investors, corporate entities, institutional clients, healthcare organizations, and laboratories across Turkey and international markets. In recent developments, Guler Yatirim Holding A.S. has executed key strategic reorganizations, subsidiary capital expansions, and business integrations to strengthen its core operations. The group successfully oversaw the public listing of its primary brokerage subsidiary, A1 Capital Yatirim Menkul Degerler A.S., on Borsa Istanbul, expanding its institutional footprint and digital brokerage infrastructure with upgraded mobile trading platforms and algorithmic execution capabilities. Its venture capital affiliate, Pardus Girisim Sermayesi Yatirim Ortakligi A.S., scaled its investment portfolio through new equity funding rounds in high-growth technology, energy storage, and industrial innovation enterprises. Concurrently, healthcare subsidiary RTA Laboratuvarlari expanded its diagnostic manufacturing capacity and international distribution channels to support broadened clinical kit export programs, while the parent holding implemented capital increases to support ongoing investments in sustainable energy assets and fintech platforms.